Aimmune Therapeutics
Aimmune Therapeutics is a biopharmaceutical company developing and commercializing treatments for patients with potentially life-threatening food allergies. Aimmune Therapeutics is headquartered in Brisbane, California with other locations around the globe.
Last updated on
About Aimmune Therapeutics
Founded
2011Estimated Revenue
$1M-$10MEmployees
51-250Funding / Mkt. Cap
$540MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
87NAICs Code
32Location
City
BrisbaneState
CaliforniaCountry
United StatesAimmune Therapeutics
Find your buyer within Aimmune Therapeutics